Approved anti-obesity medications in 2022 KSSO guidelines and the promise of phase 3 clinical trials: anti-obesity drugs in the sky and on the horizon
At Tulsi Wellness Club , we believe in providing science-backed information on peptide therapies and metabolic treatments
Always consult with your healthcare provider to determine the best treatment options for your individual needs
Diabetes Care 48(9):16221627 Kahn SE, Deanfield JE, Jeppesen OK, Emerson SS, Boesgaard TW, Colhoun HM, Kushner RF, Lingvay I, Burguera B, Gajos G, Horn DB, Hramiak IM, Jastreboff AM, Kokkinos A, Maeng M, Matos ALSA, Tinahones FJ, Lincoff AM, Ryan DH, SELECT Trial Investigators (2024) Effect of semaglutide on regression and progression of glycemia in people with overweight or obesity but without diabetes in the SELECT trial
Additionally, our comprehensive body composition analysis provides insights into your unique metrics, allowing us to personalize your treatment plan for optimal results
(2021) 33(4):833844.e5